Apriem Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-100
| Closed | -$4K | – | 628 |
|
|
2016
Q2 | $4K | Hold |
100
| – | – | ﹤0.01% | 494 |
|
|
2016
Q1 | $4K | Hold |
100
| – | – | ﹤0.01% | 467 |
|
|
2015
Q4 | $5K | Hold |
100
| – | – | ﹤0.01% | 437 |
|
|
2015
Q3 | $5K | Hold |
100
| – | – | ﹤0.01% | 412 |
|
|
2015
Q2 | $6K | Hold |
100
| – | – | ﹤0.01% | 465 |
|
|
2015
Q1 | $6K | Hold |
100
| – | – | ﹤0.01% | 460 |
|
|
2014
Q4 | $5K | Hold |
100
| – | – | ﹤0.01% | 433 |
|
|
2014
Q3 | $5K | Hold |
100
| – | – | ﹤0.01% | 441 |
|
|
2014
Q2 | $4K | Hold |
100
| – | – | ﹤0.01% | 406 |
|
|
2014
Q1 | $4K | Hold |
100
| – | – | ﹤0.01% | 423 |
|
|
2013
Q4 | $4K | Hold |
100
| – | – | ﹤0.01% | 430 |
|
|
2013
Q3 | $4K | Hold |
100
| – | – | ﹤0.01% | 428 |
|
|
2013
Q2 | $3K | Buy |
+100
| New | +$3K | ﹤0.01% | 413 |
|